PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Regenerative Biologics for Oxnard Medspas and Dermatology Practices

Medspas, dermatology offices, and aesthetic or plastic surgery practices in Oxnard, California operate under physician supervision, which shapes how they qualify a new biologics supplier and who signs off on the account. Precision Biologics distributes Wharton's jelly and exosome allograft products to NPI-verified accounts in the Oxnard-Thousand Oaks market and across the West region, with documentation structured for a medical director's review.

REGISTRY DATA / CA

Oxnard

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

14
Dermatology
13
Plastic Surgery
1
Source: NPPES NPI Registry ↗

Physician Supervision Shapes Account Structure

Because medspas typically operate under the supervision of a physician medical director rather than as an independently licensed clinical practice, the NPI tied to a new account is often the medical director's rather than the medspa's business entity. Precision Biologics verifies accounts against that NPI, and the documentation package is written so a medical director, who carries the regulatory responsibility, can review it directly.

A multi-location aesthetic group with one medical director overseeing several sites should expect the verification step to focus on that individual's NPI and licensure rather than on each site separately.

Documentation a Medical Director Will Expect

A medical director reviewing a new biologics line generally wants the lot-specific certificate of analysis, a donor eligibility and screening summary, and confirmation of third-party sterility testing before a product is added to a product menu, not marketing material. Registration and licensure documentation for the supplying tissue bank is available for a qualified buyer's own verification as well.

Precision Biologics does not provide clinical or procedural guidance; how a specific product's intended use is classified, and whether it fits the practice's scope under California's medical board rules, is a determination for the medical director and the practice's counsel.

Receiving Shipments at an Aesthetic Practice or Medspa

Cryopreserved Wharton's jelly products arrive overnight on dry ice in a validated container and should be moved to -80 C storage immediately on receipt; lyophilized exosome products are shelf-stable and do not require freezer space, which fits the storage footprint of many medspa locations. A front-desk or inventory staff member should be designated to check the lot identifier on arrival against the paperwork for every shipment, not just the first one.

These products are not FDA approved or licensed for any disease or condition. Information on this page is for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Who should be the point of contact for account verification at a medspa?+

Usually the medical director whose NPI the account is verified against, though an office manager can handle day-to-day ordering once the account is set up.

Does Precision Biologics help decide which product fits our menu?+

No. Precision Biologics supplies documentation, composition, processing description, and lot records, but the decision about intended use and fit belongs to the medical director and the practice's counsel.

Is the Dermatology and Plastic Surgery provider count for Oxnard a list of prospective clients?+

No. It's an NPPES registry count of 14 individually registered providers with a primary Oxnard address under those two taxonomy codes, retrieved October 27, 2026. It is not a lead list or a measure of local demand.